Related Experiment Video

Updated: Jun 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Analysis of adiponectin gene polymorphisms in dilated cardiomyopathy in a Han Chinese population

Yu Chen1, Ying Peng, Bin Zhou

  • 1Department of Cardiology, West China Hospital of Sichuan University, Chengdu, PR China.

DNA and Cell Biology
|March 17, 2010
PubMed

Insights

This study investigated adiponectin gene variants in dilated cardiomyopathy (DCM) patients. Adiponectin polymorphisms were not found to be associated with DCM susceptibility in the Han Chinese population.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Human Genetics

Background:

  • Dilated cardiomyopathy (DCM) is a complex heart muscle disease with poorly understood pathogenesis.
  • Adiponectin, an adipocyte-derived cytokine, possesses anti-inflammatory and antiatherogenic properties, suggesting a potential role in cardiovascular health.
  • Investigating genetic factors like adiponectin polymorphisms may offer insights into DCM etiology.

Purpose of the Study:

  • To evaluate the association between specific adiponectin gene single-nucleotide polymorphisms (SNPs), rs1501299 and rs2241766, and the risk of developing dilated cardiomyopathy.
  • To determine if variations in the adiponectin gene contribute to DCM susceptibility in the Han Chinese population.

Main Methods:

  • Genotyping of two adiponectin gene SNPs (rs1501299 and rs2241766) using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
  • Comparison of genotype and allele frequencies between 203 DCM patients and 258 healthy control subjects from the Han Chinese population.

Main Results:

  • No statistically significant differences were observed in the genotype frequencies of rs1501299 and rs2241766 between DCM patients and controls.
  • Allele frequencies for the studied adiponectin gene variants also showed no significant association with DCM in the examined cohort.

Conclusions:

  • The findings suggest that the investigated adiponectin gene polymorphisms (rs1501299 and rs2241766) are unlikely to be major genetic determinants for dilated cardiomyopathy susceptibility in the Han Chinese population.
  • Further research may be warranted to explore other genetic or environmental factors contributing to DCM pathogenesis.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...